BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 37736753)

  • 1. Serum metabolomics profiling by proton nuclear magnetic resonance spectrometry of the response to single oral macronutrient challenges in women with polycystic ovary syndrome (PCOS) compared with male and female controls.
    Escobar-Morreale HF; Martínez-García MÁ; Insenser M; Cañellas N; Correig X; Luque-Ramírez M
    Biol Sex Differ; 2023 Sep; 14(1):62. PubMed ID: 37736753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum metabolomics profiling by proton nuclear magnetic resonance spectroscopy reveals sexual dimorphism and masculinization of intermediate metabolism in women with polycystic ovary syndrome (PCOS).
    Escobar-Morreale HF; Martínez-García MÁ; Insenser M; Cañellas N; Correig X; Luque-Ramírez M
    Biol Sex Differ; 2023 Apr; 14(1):21. PubMed ID: 37076926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Cytokines at Fasting and During Macronutrient Challenges: Influence of Obesity, Female Androgen Excess and Sex.
    Martínez-García MÁ; Moncayo S; Insenser M; Álvarez-Blasco F; Luque-Ramírez M; Escobar-Morreale HF
    Nutrients; 2019 Oct; 11(11):. PubMed ID: 31652917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2D Diffusion-Ordered
    Insenser M; Moncayo S; Martínez-García MÁ; Fernández-Durán E; Samino S; Álvarez-Blasco F; Luque-Ramírez M; Escobar-Morreale HF
    Mol Nutr Food Res; 2020 May; 64(9):e1900928. PubMed ID: 32187436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postprandial inflammatory responses after oral glucose, lipid and protein challenges: Influence of obesity, sex and polycystic ovary syndrome.
    Martínez-García MÁ; Moncayo S; Insenser M; Montes-Nieto R; Fernández-Durán E; Álvarez-Blasco F; Luque-Ramírez M; Escobar-Morreale HF
    Clin Nutr; 2020 Mar; 39(3):876-885. PubMed ID: 30975555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome.
    Chang AY; Lalia AZ; Jenkins GD; Dutta T; Carter RE; Singh RJ; Nair KS
    Metabolism; 2017 Jun; 71():52-63. PubMed ID: 28521878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute-phase glycoprotein profile responses to different oral macronutrient challenges: Influence of sex, functional hyperandrogenism and obesity.
    Moncayo S; Insenser M; Martínez-García MÁ; Fuertes-Martín R; Amigó-Grau N; Álvarez-Blasco F; Luque-Ramírez M; Correig-Blanchar X; Escobar-Morreale HF
    Clin Nutr; 2021 Mar; 40(3):1241-1246. PubMed ID: 32847693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
    Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
    Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial responses of circulating energy homeostasis mediators to single macronutrient challenges: influence of obesity and sex hormones.
    Martínez-García MÁ; Moncayo S; Insenser M; Álvarez-Blasco F; Luque-Ramírez M; Escobar-Morreale HF
    Food Funct; 2021 Feb; 12(3):1051-1062. PubMed ID: 33443255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS.
    Escobar-Morreale HF; Samino S; Insenser M; Vinaixa M; Luque-Ramírez M; Lasunción MA; Correig X
    Clin Chem; 2012 Jun; 58(6):999-1009. PubMed ID: 22427353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
    Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-targeted profiling of circulating microRNAs in women with polycystic ovary syndrome (PCOS): effects of obesity and sex hormones.
    Murri M; Insenser M; Fernández-Durán E; San-Millán JL; Luque-Ramírez M; Escobar-Morreale HF
    Metabolism; 2018 Sep; 86():49-60. PubMed ID: 29410349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.
    Zwirska-Korczala K; Sodowski K; Konturek SJ; Kuka D; Kukla M; Brzozowski T; Cnota W; Woźniak-Grygiel E; Jaworek J; Bułdak R; Rybus-Kalinowska B; Fryczowski M
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels.
    Vicennati V; Gambineri A; Calzoni F; Casimirri F; Macor C; Vettor R; Pasquali R
    Metabolism; 1998 Aug; 47(8):988-92. PubMed ID: 9711997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-induced mononuclear cell cytokine secretion in the development of metabolic aberration and androgen excess in polycystic ovary syndrome.
    González F; Considine RV; Abdelhadi OA; Acton AJ
    Hum Reprod; 2020 May; 35(5):1168-1177. PubMed ID: 32325487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation Triggered by Saturated Fat Ingestion Is Linked to Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome.
    González F; Considine RV; Abdelhadi OA; Acton AJ
    J Clin Endocrinol Metab; 2020 Jun; 105(6):e2152-67. PubMed ID: 32140727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.